AI Biomed PredictionsVTVT – vTv Therapeutics Poised for Breakthrough with Diabetes Drug Tony Fogleman / July 3, 2025
AI Biomed PredictionsAMRN – Amarin Poised for Breakout with Key Approvals and Global Expansion Tony Fogleman / July 3, 2025
AI Biomed PredictionsFATE – Fate Therapeutics Poised for Breakout on Clinical Catalysts Tony Fogleman / July 3, 2025
AI Biomed PredictionsENTA – Enanta Set for Breakout on Clinical Trial Catalysts Tony Fogleman / July 3, 2025
AI Biomed PredictionsNKTR – Promising Phase 2b Trials Propel Nektar’s Investment Potential Tony Fogleman / July 3, 2025
AI Biomed PredictionsQURE – uniQure Set for Breakout Amid Promising Gene Therapy Advances Tony Fogleman / July 3, 2025
AI Biomed PredictionsXBIT – XBiotech Poised for Breakout with Upcoming Phase II Trial Results Tony Fogleman / July 3, 2025
AI Biomed PredictionsMGNX – MacroGenics Poised for Breakthrough Amid Clinical Trials Tony Fogleman / July 3, 2025
AI Biomed PredictionsVTGN – Promising Outlook for Vistagen with Upcoming Phase III Results Tony Fogleman / July 3, 2025
AI Biomed PredictionsABEO – Abeona Therapeutics Nears Transformative FDA Decision Tony Fogleman / July 3, 2025
